Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Glymide tablets (5 mg glibenclamide) Produced by Julphar / UAE versus Daonil® tablets (5 mg glibenclamide) Produced Sanofi-Aventis / Germany, in healthy subjects under fed condition.
2020-07-04
عنوان الدراسة
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Glymide tablets (5 mg glibenclamide) Produced by Julphar / UAE versus Daonil® tablets (5 mg glibenclamide) Produced Sanofi-Aventis / Germany, in healthy subjects under fed condition.
داعم الدراسة
SFDA
دواء الدراسة
Glymide
رقم بروتوكول الدراسة
13-2017
حالة الدراسة
Ongoing
موقع الدراسة
Saudi Ajal
مرحلة الدراسة
BE
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.